Response to: Letter in response to 'Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal' by M Waly, H Olteanu, Banerjee R, et al. Mol Psych 2004: (January) : 1-13 R Deth R Deth responds to a letter from Offit and Golden concerning thimerosal-induced inhibition of methionine synthase as a plausible mechanism for causing autism. He points out that thimerosal has indeed been demonstrated to enter the brain in primate studies and that its inhibitory effects on methionine synthase are observed in several cell types. While some epidemiologic studies failed to detect an association between thimerosal and autism, studies on autistic children show an impaired ability to detoxify heavy metals.
FEATURE REVIEWS
Autism as a disorder of neural information processing: directions for research and targets for therapy MK Belmonte, EH Cook Jr, GM Anderson, JLR Rubenstein, WT Greenough, A Beckel-Mitchener, E Courchesne, LM Boulanger, SB Powell, PR Levitt, EK Perry, Y Jiang, TM DeLorey, E Tierney Autism's specific anatomic and behavioral features may result from the interaction of normal developmental programs with a pervasive deficit in neural information processing. Findings from structural and functional imaging, neuropathology and neurophysiology seem consistent with a hypothesis of abnormal neural connectivity, arising from multiple predisposing factors and producing multiple cognitive and behavioral abnormalities. Well-defined endophenotypes within autism and the broader autism phenotype, as well as syndromes that share symptoms with autism, will lead to the identification of therapeutic targets.
Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior, and therapy J Götz, JR Streffer, D David, A Schild, F Hoerndli, L Pennanen, P Kurosinski, F Chen
To assist in the elucidation of pathogenic mechanisms of Alzheimer's disease and related disorders, such as frontotemporal dementia, genetically modified mice, flies, fish and worms were developed that reproduce aspects of the human histopathology, such as bamyloid-containing plaques and tau-containing neurofibrillary tangles. This review aims to discuss the suitability and limitations of the various animal models and their contribution, both to the understanding of the pathophysiology of AD and related disorders and the development of treatment therapies.
IMMEDIATE COMMUNICATION
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress S Prabakaran, JE Swatton, MM Ryan, SJ Huffaker, JT-J Huang, JL Griffin, M Wayland, T Freeman, F Dudbridge, KS Lilley, NA Karp, S Hester, D Tkachev, ML Mimmack, RH Yolken, MJ Webster, EF Torrey, S Bahn A large-scale functional genomics study was performed to characterize the schizophrenia prefrontal cortex at the transcript, protein and metabolite level. The authors found converging evidence that suggest a state of intermittent or chronic low-grade hypoxic stress and mitochondrial dysfunction, possibly due to local ischemia or abnormal glucose utilization. They hypothesized that diverse genetic and/or epigenetic factors predispose and precipitate hypoxic events in a constitutively vulnerable prefrontal cortex (ie as a result of altered microcirculation or glucose/oxygen utilization) and in turn lead to the acute and chronic deficits, characteristic of schizophrenia.
ORIGINAL RESEARCH ARTICLES
Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype T Li, H Stefansson, E Gudfinnsson, G Cai, X Liu, RM Murray, V Steinthorsdottir, D Januel, VG Gudnadottir, H Petursson, A Ingason, JR Gulcher, K Stefansson, DA Collier
The neuregulin 1 gene (NRG1), originally identified in Iceland and subsequently confirmed in Scotland, is a genetic risk factor for schizophrenia in European populations. The authors examined Han Chinese schizophrenic patients and their families and found that NRG1 is also a risk factor for schizophrenia. The segment of the gene associated with schizophrenia is in the same location as in European populations, narrowing down the susceptibility region and thus facilitating the search for the actual risk alleles. Genetic factors contribute to development of attention deficit hyperactivity disorder (ADHD). The authors tested the genetic association of DNA variations in three dopamine receptors (DRD2, DRD4 and DRD5) and the dopamine transporter (DAT1) with ADHD in about 270 families with multiple affected children. It was found that DNA variants in the promoter region of DRD4 or near DRD5 are significantly associated with ADHD in these families, but the effects were small.
The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder ME Avale, TL Falzone, DM Gelman, MJ Low, DK Grandy, M Rubinstein
The authors investigated the participation of the D4R in a mouse model where neonatal disruption of dopamine neurons leads to juvenile hyperactivity, poor behavioral inhibition and paradoxical calming responses to psychostimulants. Administration of a D4R antagonist prevented hyperactivity in this mouse model. In addition, mice lacking D4Rs did not develop hyperactivity or loss of behavioral inhibition. Together, these results suggest that D4R signaling is essential for the expression of relevant features present in this ADHD-like mouse model.
